Kirk N. Campbell - Publications

Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 04, 2026

Beyond Genotype: Multidomain Biomarker-Integrated Risk Scores Reveal Prognostic phenotypes Among Individuals with High-Risk APOL1 Genotypes.

Journal: medRxiv : the preprint server for health sciences

Published: June 12, 2026

Podocyte-Targeted Therapy in Focal Segmental Glomerulosclerosis: Insights From a Phase 2 Trial of TRPC6 Inhibition.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: April 18, 2026

Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Journal: Kidney international

Published: February 05, 2026

Communication leading to injury: podocyte-derived fibrillin-1 induces mesangial cell activation and proliferation through EGFR signaling.

Journal: Kidney international

Published: February 02, 2026

Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine Project.

Journal: Kidney medicine

Published: February 02, 2026

Immunoglobulin A Nephropathy: New Treatment Options.

Journal: Annual review of medicine

Published: January 27, 2026

Family Matters: Dissecting the Impact of Family Medical History, APOL1 Genotype, and Sociodemographic Factors on CKD Progression in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: January 09, 2026

Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 18, 2025

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy.

Journal: The New England journal of medicine

Published: November 06, 2025

Improving the Histologic Classification of Advanced Diabetic Nephropathy Based on the Transformative Research in Diabetic Nephropathy (TRIDENT) Findings.

Journal: Kidney international

Published: September 26, 2025

Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans.

Journal: Science translational medicine

Published: June 25, 2025